| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |